Reuters logo
2 months ago
BRIEF-Pfizer receives Health Canada approval for Ibrance in hr+, her2- metastatic breast cancer
June 21, 2017 / 12:17 PM / 2 months ago

BRIEF-Pfizer receives Health Canada approval for Ibrance in hr+, her2- metastatic breast cancer

June 21 (Reuters) - Pfizer Inc

* Pfizer receives expanded Health Canada approval for ibrance in hr+, her2- metastatic breast cancer Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below